Timing of cancer chemotherapy is crucial for the success of treatment
Back in the year 1980, R. North an immunologist from the Trudeau Institute in New York and colleagues were able to produce immune cycling with tumor regression by directing chemotherapy to immune suppressor cells. He also reported that if chemotherapy was given at the wrong day and earlier, it will not work, instead the tumor will grow faster and will give the impression that the tumor was resistant to the chemotherapy drug. (Science Magazine,May 2010)
While several of the IPT doctors that I have trained on Insulin Potentiation Therapy (IPT) and some patients who have a cancer recurrence are concerned with finding which chemotherapy drug will work best I tell them that to have a successful treatment of cancer depends on the accurate timing of delivering chemotherapy to match the fluctuation in each patient's immune system.
Not all cancer patients are cured by surgery, radiotherapy, biological therapies, alternative treatments, standard high dose chemotherapy or even low dose chemo. Some patients achieve a complete regression, others do not respond and others appear to have some level of clinical response.
Traditional cancer therapies affect some cancer cells but also normal cells and produce the well known side effects.
Today September 2010, my Insulin Potentiation Therapy +Targeted Low Dose chemotherapy has been taking advantage of the immune system cycle using it's regulatory mechanism by enhancing selectively the T cells in a cycle specific manner due to the actions of the insulin that acts as a modifier of the cell biologic response. Insulin enhances (potentiates) the anticancer effects of chemotherapy drugs.
Since Donato Perez Garcia,MD (1896-1971) the creator on this treatment for cancer and chronic degenerative diseases started to treat patients, he set the treatment appointments for every 7 days, this was back in the year 1930 for chronic degenerative diseases and in 1946 for cancer. He noted that patients had very good responses when they received their chemotherapy every 7 days. It was the time when observation and good clinical judgment played an important factor. His observations came to scientific support until the year 2009 when a team of Medical Doctors (Coventry, Ashdown, Quinn, Markovic, Yatomi-Clarke & Robinson) from Department of Surgery & Tumor Immunology Laboratory, University of Adelaide, Royal Adelaide Hospital, Adelaide South Australia identified the homeostatic immune oscillations in cancer patients that CR a protein indicated. This CRP is associated with inflammation and the activation of the immune system. (Journal of Translational Medicine 2009,7:102)
To my patients treated here in Tijuana, Baja California this means that they are receiving their chemotherapy protocol on the correct day, achieving the disruption of the regulatory circuits that protect the tumor cells. With my IPTLD protocol my patients are also taking advantage of the induced and controlled hyperthermia that insulin produces and it is well known that a high body temperature also helps in the fight against cancer.
I started to treat cancer and chronic degenerative disease patients back in 1983 and during these 28 years or clinical practice I have seen several cancer patients that were initially treated with standard chemotherapy, responded well but later developed a cancer recurrence. Several of these patients who developed a metastases or recurrence were told that they build chemo resistance. When I started to treat them using the low dose insulin that acts as a modifier of the cell biologic response with the same chemo drugs they received as their first treatment they all had a good response. No need to mention that the Greek test to detect chemotherapeutic drugs sensitivity was not available.
CONCLUSION: To over come resistance of chemotherapy drugs -when they stopped working- the pre-treatment administration of insulin as it is done on IPTLD, is the solution to enhance the effect of the chemotherapy drug, making the use of insulin an important one to deliver effectively your chemotherapy drug combination at the right time and day to match your immune system activity . If the problem of making the chemo drug effective is solved by the pre-treatment administration of insulin, the sensitivity test to different chemo agents may not be as necessary as you may think in order to treat metastases or recurrences, because when the drugs are given on the right time and day, the response is a success. I have seen this happen many times during my 28 years of clinical experience with IPTLD/IPT and no other IPT doctor can compete with my long clinical experience of doing IPT/IPTLD.
Back in the year 1980, R. North an immunologist from the Trudeau Institute in New York and colleagues were able to produce immune cycling with tumor regression by directing chemotherapy to immune suppressor cells. He also reported that if chemotherapy was given at the wrong day and earlier, it will not work, instead the tumor will grow faster and will give the impression that the tumor was resistant to the chemotherapy drug. (Science Magazine,May 2010)
While several of the IPT doctors that I have trained on Insulin Potentiation Therapy (IPT) and some patients who have a cancer recurrence are concerned with finding which chemotherapy drug will work best I tell them that to have a successful treatment of cancer depends on the accurate timing of delivering chemotherapy to match the fluctuation in each patient's immune system.
Not all cancer patients are cured by surgery, radiotherapy, biological therapies, alternative treatments, standard high dose chemotherapy or even low dose chemo. Some patients achieve a complete regression, others do not respond and others appear to have some level of clinical response.
Traditional cancer therapies affect some cancer cells but also normal cells and produce the well known side effects.
Today September 2010, my Insulin Potentiation Therapy +Targeted Low Dose chemotherapy has been taking advantage of the immune system cycle using it's regulatory mechanism by enhancing selectively the T cells in a cycle specific manner due to the actions of the insulin that acts as a modifier of the cell biologic response. Insulin enhances (potentiates) the anticancer effects of chemotherapy drugs.
Since Donato Perez Garcia,MD (1896-1971) the creator on this treatment for cancer and chronic degenerative diseases started to treat patients, he set the treatment appointments for every 7 days, this was back in the year 1930 for chronic degenerative diseases and in 1946 for cancer. He noted that patients had very good responses when they received their chemotherapy every 7 days. It was the time when observation and good clinical judgment played an important factor. His observations came to scientific support until the year 2009 when a team of Medical Doctors (Coventry, Ashdown, Quinn, Markovic, Yatomi-Clarke & Robinson) from Department of Surgery & Tumor Immunology Laboratory, University of Adelaide, Royal Adelaide Hospital, Adelaide South Australia identified the homeostatic immune oscillations in cancer patients that CR a protein indicated. This CRP is associated with inflammation and the activation of the immune system. (Journal of Translational Medicine 2009,7:102)
To my patients treated here in Tijuana, Baja California this means that they are receiving their chemotherapy protocol on the correct day, achieving the disruption of the regulatory circuits that protect the tumor cells. With my IPTLD protocol my patients are also taking advantage of the induced and controlled hyperthermia that insulin produces and it is well known that a high body temperature also helps in the fight against cancer.
I started to treat cancer and chronic degenerative disease patients back in 1983 and during these 28 years or clinical practice I have seen several cancer patients that were initially treated with standard chemotherapy, responded well but later developed a cancer recurrence. Several of these patients who developed a metastases or recurrence were told that they build chemo resistance. When I started to treat them using the low dose insulin that acts as a modifier of the cell biologic response with the same chemo drugs they received as their first treatment they all had a good response. No need to mention that the Greek test to detect chemotherapeutic drugs sensitivity was not available.
CONCLUSION: To over come resistance of chemotherapy drugs -when they stopped working- the pre-treatment administration of insulin as it is done on IPTLD, is the solution to enhance the effect of the chemotherapy drug, making the use of insulin an important one to deliver effectively your chemotherapy drug combination at the right time and day to match your immune system activity . If the problem of making the chemo drug effective is solved by the pre-treatment administration of insulin, the sensitivity test to different chemo agents may not be as necessary as you may think in order to treat metastases or recurrences, because when the drugs are given on the right time and day, the response is a success. I have seen this happen many times during my 28 years of clinical experience with IPTLD/IPT and no other IPT doctor can compete with my long clinical experience of doing IPT/IPTLD.
